Has George Bailes, MD received payments from drug or device companies?

Yes. Drug and device makers reported $22,480 in general payments to George Bailes, MD across 472 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean George Bailes, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about George Bailes, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

George Bailes, MD

Family Medicine · Spartanburg, SCNPI 1417935339

Payments from drug & device makers

$22,480in general payments, 2019–2025

Across 472 payments — averaging $47.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

G1 Therapeutics, Inc.$15K
AbbVie$847
Pfizer$617
Novo Nordisk$584
AstraZeneca$489
GSK$486
plus $4K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
G1 Therapeutics, Inc.	2	$15,000
AbbVie(2 entities)	67	$847
Pfizer	39	$617
Novo Nordisk	42	$584
AstraZeneca(2 entities)	31	$489
GSK	36	$486
Abbott	15	$320
Amgen	20	$320
Boehringer Ingelheim	14	$206
Daiichi Sankyo Inc.	11	$206
Bayer	10	$172
Lilly USA, LLC	12	$171
Sanofi-aventis U.S. LLC	9	$155
Amarin Pharma, Inc.	9	$144
Dexcom, Inc.	8	$141
Esperion Therapeutics, Inc.	7	$136
Novartis	8	$136
Takeda Pharmaceuticals U.S.A., Inc.	9	$132
Merck	8	$126
Mannkind Corporation	7	$123
Seqirus USA Inc	6	$119
Astellas Pharma US Inc	6	$105
Antares Pharma, Inc.	7	$99
Biohaven Pharmaceuticals, Inc.	4	$91
Medtronic	2	$88
Eisai Inc.	4	$82
Kowa Pharmaceuticals America, Inc.	6	$77
Exact Sciences	5	$74
Abiomed	3	$71
Biohaven Pharmaceutical Holding Company Ltd.	4	$70
Phathom Pharmaceuticals, Inc.	4	$70
Genentech USA, Inc.	4	$62
Xeris Pharmaceuticals, Inc.	3	$56
Insulet Corporation	2	$54
Johnson & Johnson	3	$51
Sumitomo Pharma America, Inc.	3	$51
Recor Medical Inc	2	$49
VBI Vaccine (delaware) Inc.	2	$44
Clarus Therapeutics Inc.	3	$44
Halozyme Inc	2	$40
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$39
Mylan Specialty L.p.	2	$39
Inari Medical, Inc.	2	$34
Corcept Therapeutics	2	$31
Zealand Pharma US, Inc.	1	$29
Arbor Pharmaceuticals, Inc.	1	$29
Currax Pharmaceuticals LLC	2	$28
Verona Pharma, Inc.	1	$26
Ironwood Pharmaceuticals, Inc	2	$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$24
Stryker	1	$22
Nabriva Therapeutics, PLC	1	$19
Axsome Therapeutics, Inc.	1	$19
Tonix Medicines, Inc.	1	$18
Edwards Lifesciences	1	$18
Idorsia Pharmaceuticals US Inc	1	$17
Cranial Technologies, Inc	1	$16
E.r. Squibb & Sons, L.L.C.	1	$16
Philips North America LLC	1	$16
Vivus LLC	1	$15

How this compares

$22,480 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$332,805

Medicare patients

505

Services billed

9,181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Spartanburg

Latasha SelibySpartanburg$24K
Cayce TangemanGoose Creek$8.4M
Jeremy AckermannMoncks Corner$7.6M
Kelly MoralesNorth Charleston$6.5M
William ByarsGreer$4.8M
James FranklinGreenville$3.5M
Stephen GrubbLittle River$3.4M
Jeffrey HarrisGreenville$3.4M
Shannon ConradN Charleston$3.3M
Tom ChristensenLittle River$3.1M

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →